• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液单采术中的抗凝技术:从肝素到枸橼酸盐及其他

Anticoagulation techniques in apheresis: from heparin to citrate and beyond.

作者信息

Lee Grace, Arepally Gowthami M

机构信息

Division of Hematology and Medical Oncology, Duke University Medical Center, Durham, North Carolina, USA.

出版信息

J Clin Apher. 2012;27(3):117-25. doi: 10.1002/jca.21222. Epub 2012 Apr 24.

DOI:10.1002/jca.21222
PMID:22532037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3366026/
Abstract

Anticoagulation is essential for maintaining the fluidity of extravascular blood on the apheresis circuit. Although both citrate and heparin are used as an anticoagulant during apheresis, citrate is preferred for the majority of exchange procedures because of its safety and effectiveness. Complications of citrate are primarily due to physiologic effects of hypocalcemia. Symptoms of hypocalcemia and other citrate-induced metabolic abnormalities affect neuromuscular and cardiac function and range in severity from mild dysesthesias (most common) to tetany, seizures, and cardiac arrhythmias. Oral or intravenous calcium supplementation is advised for decreased ionized calcium levels and/or symptomatic management of hypocalcemia. Heparin-based anticoagulation is limited to certain apheresis procedures (membrane-based plasma exchange, LDL apheresis, or photopheresis) or is used in combination with citrate to reduce citrate load. While effective, heparin anticoagulation is associated with an increased frequency of bleeding complications and heparin-induced thrombocytopenia. J. Clin. Apheresis 2012. © 2012 Wiley Periodicals, Inc.

摘要

抗凝对于维持单采回路中血管外血液的流动性至关重要。虽然在单采过程中枸橼酸盐和肝素都用作抗凝剂,但由于其安全性和有效性,枸橼酸盐在大多数置换程序中更受青睐。枸橼酸盐的并发症主要是由于低钙血症的生理效应。低钙血症的症状以及其他枸橼酸盐诱导的代谢异常会影响神经肌肉和心脏功能,严重程度从轻度感觉异常(最常见)到手足搐搦、癫痫发作和心律失常不等。对于离子钙水平降低和/或低钙血症的症状处理,建议口服或静脉补充钙剂。基于肝素的抗凝仅限于某些单采程序(膜式血浆置换、低密度脂蛋白单采或光化学单采),或者与枸橼酸盐联合使用以减少枸橼酸盐负荷。虽然肝素抗凝有效,但其与出血并发症和肝素诱导的血小板减少症的发生率增加有关。《临床单采杂志》2012年。©2012威利期刊公司。

相似文献

1
Anticoagulation techniques in apheresis: from heparin to citrate and beyond.血液单采术中的抗凝技术:从肝素到枸橼酸盐及其他
J Clin Apher. 2012;27(3):117-25. doi: 10.1002/jca.21222. Epub 2012 Apr 24.
2
Regional citrate anticoagulation with calcium replacement in pediatric apheresis.小儿血液分离术中采用钙剂补充的局部枸橼酸盐抗凝法。
J Clin Apher. 2018 Jun;33(3):274-277. doi: 10.1002/jca.21594. Epub 2017 Oct 13.
3
Comparative evaluation of a heparin-citrate anticoagulation for LDL-apheresis in two primary apheresis systems.两种主要血液分离系统中肝素-枸橼酸盐抗凝用于低密度脂蛋白血液分离术的比较评估
J Clin Apher. 2017 Oct;32(5):319-328. doi: 10.1002/jca.21512. Epub 2016 Sep 27.
4
A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.一项在危重症成人中连续肾脏替代治疗时局部枸橼酸抗凝与局部肝素抗凝的随机对照试验。
Crit Care Med. 2015 Aug;43(8):1622-9. doi: 10.1097/CCM.0000000000001004.
5
Heparin-free DALI LDL-apheresis in hyperlipidemic patients: efficacy, safety and biocompatibility.高脂血症患者的无肝素DALI低密度脂蛋白分离术:疗效、安全性和生物相容性。
Int J Artif Organs. 2000 Oct;23(10):710-7.
6
Application of regional citrate anticoagulation in membrane therapeutic plasma exchange.局部枸橼酸抗凝在膜式治疗性血浆置换中的应用。
Int Urol Nephrol. 2020 Dec;52(12):2379-2384. doi: 10.1007/s11255-020-02581-0. Epub 2020 Aug 1.
7
Regional citrate anticoagulation--a safe and effective procedure in pediatric apheresis therapy.区域性柠檬酸盐抗凝——儿科血液净化治疗中的一种安全有效的方法。
Pediatr Nephrol. 2011 Jan;26(1):127-32. doi: 10.1007/s00467-010-1658-z. Epub 2010 Oct 21.
8
Treatment for the decline of ionized calcium levels during peripheral blood progenitor cell harvesting.外周血祖细胞采集期间离子钙水平下降的治疗方法。
Transfusion. 2002 Oct;42(10):1340-7. doi: 10.1046/j.1537-2995.2002.00205.x.
9
A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).一种用于连续性静脉-静脉血液透析(CVVHD)的局部枸橼酸盐抗凝新系统。
Clin Nephrol. 2003 Feb;59(2):106-14. doi: 10.5414/cnp59106.
10
Citrate versus heparin for apheresis catheter locks: an efficacy analysis.用于单采导管封管的枸橼酸盐与肝素:疗效分析
J Clin Apher. 2015 Feb;30(1):22-7. doi: 10.1002/jca.21346. Epub 2014 Aug 13.

引用本文的文献

1
Novel method for autologous peripheral blood stem cell harvest using highly concentrated sodium citrate solution replacing acid citrate dextrose solution A.使用高浓度柠檬酸钠溶液替代酸性枸橼酸盐葡萄糖溶液A进行自体外周血干细胞采集的新方法。
Transfusion. 2025 Sep;65(9):1662-1672. doi: 10.1111/trf.18360. Epub 2025 Jul 25.
2
Anticoagulant regimens for different therapeutic plasma exchange modes.不同治疗性血浆置换模式的抗凝方案。
Front Med (Lausanne). 2025 Jun 18;12:1568333. doi: 10.3389/fmed.2025.1568333. eCollection 2025.
3
Influence of anticoagulant on the spectroscopic analysis of drying bovine blood pools.

本文引用的文献

1
Comparison of citrate anticoagulation during plasma exchange with different replacement solutions.不同置换液在血浆置换过程中枸橼酸盐抗凝效果的比较。
Ther Apher Dial. 2009 Aug;13(4):322-6. doi: 10.1111/j.1744-9987.2009.00733.x.
2
Adverse reactions during voluntary donation of blood and/or blood components. A statistical-epidemiological study.自愿献血和/或血液成分期间的不良反应。一项统计流行病学研究。
Blood Transfus. 2007 Jul;5(3):143-52. doi: 10.2450/2007.0005-07.
3
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program.
抗凝剂对干燥牛血池光谱分析的影响。
J Forensic Sci. 2025 Sep;70(5):1733-1745. doi: 10.1111/1556-4029.70088. Epub 2025 May 19.
4
Novel method of leukocytapheresis using a highly concentrated sodium citrate solution alternative to acid citrate dextrose solution A.使用高浓度柠檬酸钠溶液替代酸性枸橼酸盐葡萄糖溶液A进行白细胞去除术的新方法。
Transfusion. 2025 Jul;65(7):1223-1230. doi: 10.1111/trf.18280. Epub 2025 May 19.
5
Intra-apheresis Cycling to Improve the Clinical Efficacy of Peripheral Blood Stem Cell Donations.单采术中循环以提高外周血干细胞捐献的临床疗效。
Sports Med. 2025 May;55(5):1085-1096. doi: 10.1007/s40279-025-02183-9. Epub 2025 Apr 15.
6
Indications and complications associated with centrifuge-based therapeutic plasma exchange - a retrospective review.基于离心机的治疗性血浆置换的适应症及并发症——一项回顾性研究
BMC Nephrol. 2025 Feb 19;26(1):87. doi: 10.1186/s12882-025-03970-2.
7
Correlation and mediation analysis between plasmapheresis donation behavior and bone mineral density and bone metabolism biomarkers: a cross-sectional study based on plasmapheresis donors at high risk of osteoporosis in China.血浆置换捐献行为与骨密度及骨代谢生物标志物之间的相关性和中介分析:一项基于中国骨质疏松高危血浆置换捐献者的横断面研究。
PeerJ. 2024 Dec 19;12:e18589. doi: 10.7717/peerj.18589. eCollection 2024.
8
Oral calcium supplementation versus placebo in mitigating citrate reactions during apheresis: an open-label randomized control trial.口服补钙与安慰剂减轻单采过程中枸橼酸盐反应的比较:一项开放标签随机对照试验。
Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S234-S240. doi: 10.1016/j.htct.2024.06.010. Epub 2024 Sep 20.
9
Adverse Events and Outcomes of High-volume Plasma Exchange in 50 Acute Liver Failure Patients: A Monocentric Retrospective Real-world Study.50例急性肝衰竭患者大容量血浆置换的不良事件及结局:一项单中心回顾性真实世界研究
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):101934. doi: 10.1016/j.jceh.2024.101934. Epub 2024 Jul 15.
10
Tartronic Acid as a Potential Inhibitor of Pathological Calcium Oxalate Crystallization.塔托酸作为病理性草酸钙结晶潜在抑制剂的研究。
Adv Sci (Weinh). 2024 Jun;11(21):e2400642. doi: 10.1002/advs.202400642. Epub 2024 Apr 22.
2408名非亲属外周血干细胞捐献者的不良事件:来自国家骨髓捐献项目的一项前瞻性试验结果
Blood. 2009 Apr 9;113(15):3604-11. doi: 10.1182/blood-2008-08-175323. Epub 2009 Feb 3.
4
Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).抗凝和溶栓治疗的出血并发症:美国胸科医师学会循证临床实践指南(第8版)
Chest. 2008 Jun;133(6 Suppl):257S-298S. doi: 10.1378/chest.08-0674.
5
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).胃肠外抗凝剂:美国胸科医师学会循证临床实践指南(第8版)
Chest. 2008 Jun;133(6 Suppl):141S-159S. doi: 10.1378/chest.08-0689.
6
A case report of uncompensated alkalosis induced by daily plasmapheresis in a patient with thrombotic thrombocytopenic purpura.
Ther Apher Dial. 2008 Feb;12(1):86-90. doi: 10.1111/j.1744-9987.2007.00547.x.
7
Continuous infusion of calcium gluconate in 5% albumin is safe and prevents most hypocalcemic reactions during therapeutic plasma exchange.在5%白蛋白中持续输注葡萄糖酸钙是安全的,并且可预防治疗性血浆置换过程中的大多数低钙血症反应。
J Clin Apher. 2007;22(5):265-9. doi: 10.1002/jca.20142.
8
Clinical practice. Heparin-induced thrombocytopenia.临床实践。肝素诱导的血小板减少症。
N Engl J Med. 2006 Aug 24;355(8):809-17. doi: 10.1056/NEJMcp052967.
9
Complications of therapeutic plasma exchange: experience with 4857 treatments.治疗性血浆置换的并发症:4857次治疗的经验
Ther Apher Dial. 2005 Oct;9(5):391-5. doi: 10.1111/j.1744-9987.2005.00319.x.
10
Complications of donor apheresis.供体单采术的并发症。
J Clin Apher. 2006 Jul;21(2):132-41. doi: 10.1002/jca.20039.